Population-based study on prognostic factors for recurrence and progression in primary stage T1 bladder tumours

Scandinavian Journal of Urology

Volumn 47, Issue 3, 2013, Pages 188-195

  Olsson, Hans ^a   Hultman, Per ^a   Rosell, Johan ^b   Jahnson, Staffan ^c,d  

^a Department of Clinical and Experimental Medicine ^*  (Sweden)

^b Regional Cancer Centre   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

^d Department of Clinical Immunology and Transfusion Medicine   (Sweden)

Author keywords

Lymphovascular invasion; Prognostic factors; Stage T1; Urinary bladder cancer.

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER MORTALITY; CANCER STAGING; COHORT ANALYSIS; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RECURRENCE RISK; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME; UROTHELIAL CARCINOMA OF THE BLADDER; WORLD HEALTH ORGANIZATION;

AGED; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; TUMOR BURDEN; URINARY BLADDER NEOPLASMS;

EID: 84880386767     PISSN: 21681805     EISSN: 21681813     Source Type: Journal    
DOI: 10.3109/00365599.2012.719539     Document Type: Article

References (23)

1. Ely S. Personalized medicine: Individualized care of cancer patients. Transl Res 2009;154:303-8
2. Herr HW, Donat SM, Dalbagni G. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? J Urol 2007;177:75-9; discussion 9
3. Andius P, Holmang S. Bacillus Calmette-Guerin therapy in stage Ta/T1 bladder cancer: Prognostic factors for time to recurrence and progression. BJU Int 2004;93:980-4
4. Shahin O, Thalmann GN, Rentsch C, Mazzucchelli L, Studer UE. A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stageT1grade 3 bladder cancer: Recurrence, progression and survival. J Urol 2003;169:96-100; discussion 100
5. Kondylis FI,DemirciS, LadagaL,KolmP, SchellhammerPF. Outcomes after intravesical bacillus Calmette-Guerin are not affected by substaging of high grade T1 transitional cell carcinoma. J Urol 2000;163:1120-3
6. Soukup V, Babjuk M, Duskova J, Pesl M, Szakaczova M, Zamecnik L, et al. Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in T1 urothelial urinary bladder carcinoma? Urol Int 2008;80:413-18
7. Orsola A, Trias I, Raventos CX, Espanol I, Cecchini L, Bucar S, et al. Initial high-grade T1 urothelial cell carcinoma: Feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-Treated and BCGnon- treated patients. Eur Urol 2005;48:231-8; discussion 8
8. Streeper NM, Simons CM, Konety BR, Muirhead DM, Williams RD, O'Donnell MA, et al. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer. BJU Int 2009; 103:475-9
9. Kunju LP, You L, Zhang Y, Daignault S, Montie JE, Lee CT. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens. J Urol 2008;180:1928-32; discussion 32
10. Cho KS, Seo HK, Joung JY, Park WS, Ro JY, Han KS, et al. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer. J Urol 2009; 182:2625-30
11. Lopez-Beltran A, Luque RJ, Alvarez-Kindelan J, Quintero A, Merlo F, Requena MJ, et al. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: The role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters. Am J Clin Pathol 2004;122:444-52
12. Castillo-MartinM,Domingo-DomenechJ,Karni-SchmidtO, Matos T, Cordon-Cardo C. Molecular pathways of urothelial development and bladder tumorigenesis. Urol Oncol 2010; 28:401-8
13. Cordon-Cardo C. Molecular alterations associated with bladder cancer initiation and progression. Scand J Urol Nephrol Suppl 2008:154-65
14. Lindgren D, Frigyesi A, Gudjonsson S, Sjodahl G, Hallden C, Chebil G, et al. Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome. Cancer Res 2010;70:3463-72
15. van Rhijn BW, Liu L, Vis AN, Bostrom PJ, Zuiverloon TC, Fleshner NE, et al. Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer. BJU Int 2012;Mar27. [Epub ahead of print].
16. Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49: 466-5; discussion 75-7
17. Sobin LH, Fleming ID. TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997;80:1803-4
18. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998; 22:1435-48
19. Reuter VE, Epstein JI, Amin MB, Mostofi FK. The "WHO/ ISUP Consensus Classification of Urothelial (Transitional Cell) Neoplasms": Continued discussion. Hum Pathol 1999; 30:879-80
20. Algaba F. Lymphovascular invasion as a prognostic tool for advanced bladder cancer. Curr Opin Urol 2006;16:367-71
21. Brauers A, Buettner R, Jakse G. Second resection and prognosis of primary high risk superficial bladder cancer: Is cystectomy often too early? J Urol 2001;165:808-10
22. van Rhijn BW, van der Kwast TH, Alkhateeb SS, Fleshner NE, van Leenders GJ, Bostrom PJ, et al. A new and highly prognostic system to discern T1 bladder cancer substage. Eur Urol 2012;61:378-84
23. Lee MC, Levin HS, Jones JS. The role of pathology review of transurethral bladder tumor resection specimens in the modern era. J Urol 2010;183:921-7